Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part II. Identification of the 1,3,8-triazaspiro[4,5]decan-4-one privileged structure that engenders PLD2 selectivity
Author:
Robert Lavieri,Sarah A. Scott,Jana A. Lewis,Paige E. Selvy,Michelle D. Armstrong,H. Alex Brown,Craig W. Lindsley
Publication:
Bioorganic & Medicinal Chemistry Letters
Copyright © 2009 Elsevier Ltd. All rights reserved.